Published on in Vol 12 (2023)

This is a member publication of University of Toronto

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/53556, first published .
AI Conversational Agent to Improve Varenicline Adherence: Protocol for a Mixed Methods Feasibility Study

AI Conversational Agent to Improve Varenicline Adherence: Protocol for a Mixed Methods Feasibility Study

AI Conversational Agent to Improve Varenicline Adherence: Protocol for a Mixed Methods Feasibility Study

Nadia Minian   1, 2, 3, 4, 5 , PhD ;   Kamna Mehra   1 , MSc, DNB ;   Mackenzie Earle   1 , BSc ;   Sowsan Hafuth   1 , BSc ;   Ryan Ting-A-Kee   1 , PhD ;   Jonathan Rose   1, 6 , PhD ;   Scott Veldhuizen   1, 2 , PhD ;   Laurie Zawertailo   1, 3, 4 , PhD ;   Matt Ratto   7, 8 , PhD ;   Osnat C Melamed   1, 2, 3, 5 , MSc, MD ;   Peter Selby   1, 2, 3, 9, 10 , MBBS, MHSc

1 INTREPID Lab, Centre for Addiction and Mental Health, Toronto, ON, Canada

2 Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada

3 Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada

4 Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada

5 Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada

6 Edward S. Rogers Sr. Department of Electrical and Computer Engineering, University of Toronto, Toronto, ON, Canada

7 Faculty of Information, University of Toronto, Toronto, ON, Canada

8 Schwartz Reisman Institute for Technology and Society, University of Toronto, Toronto, ON, Canada

9 Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada

10 Department of Psychiatry, University of Toronto, Toronto, ON, Canada

Corresponding Author: